Referral Guidelines

Clinical Oncology

The clinical oncology area of interest involves clinical research designed to evaluate cancer treatment.This category includes all Phase 0, I, II and III clinical trials using drugs and biological agents, including gene therapy. Preclinical studies that address specific issues related to the design of a clinical trial may be included in this category, but should not be the objective of the grant application.

Studies conducted with the intent of selecting patients for therapy and predicting response to specific therapies:

Pharmacology of drug synergism and multi-agent therapy

Predictability, reversibility and mechanisms of drug-induced toxicity in vitro and/or in vivo test systems to access efficacy of therapy

Ethical issues in human subject research as it relates to clinical trial participation, such as informed consent, data and safety monitoring, enrollment/accrual of participants, inclusion of children, and research oversight

Surgical Oncology

Interventional studies in which surgery is the dominant feature to prevent, diagnose, stage, or treat cancer; all surgical specialties, except neurosurgery and eye surgery, are included

Novel infusion/perfusion devices for use with biological or chemotherapeutic agents

Development and improvement of instruments for detection or diagnosis of tumors where surgery/biopsies is the dominant feature process